Advertisement
Canada markets close in 5 hours 50 minutes
  • S&P/TSX

    21,954.02
    +68.64 (+0.31%)
     
  • S&P 500

    5,102.65
    +54.23 (+1.07%)
     
  • DOW

    38,285.77
    +199.97 (+0.53%)
     
  • CAD/USD

    0.7319
    -0.0004 (-0.05%)
     
  • CRUDE OIL

    83.93
    +0.36 (+0.43%)
     
  • Bitcoin CAD

    87,990.16
    +1,127.37 (+1.30%)
     
  • CMC Crypto 200

    1,383.71
    -12.82 (-0.95%)
     
  • GOLD FUTURES

    2,353.90
    +11.40 (+0.49%)
     
  • RUSSELL 2000

    1,998.35
    +17.23 (+0.87%)
     
  • 10-Yr Bond

    4.6530
    -0.0530 (-1.13%)
     
  • NASDAQ

    15,903.79
    +292.03 (+1.87%)
     
  • VOLATILITY

    15.22
    -0.15 (-0.97%)
     
  • FTSE

    8,132.52
    +53.66 (+0.66%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6832
    +0.0011 (+0.16%)
     

Stocks in play: Psyched Wellness Ltd.

Announced that it is one of the 17 companies in the United States and Canada that will be included in the first psychedelic exchange-traded fund, which is managed by Horizons ETF Management. The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, Jan. 26, 2021, under the ticker PSYK on the NEO Exchange. "We are pleased to be included in the first psychedelics ETF and to be recognized as one of the leading company in the field of psychedelic health and wellness and pharmaceuticals," said Jeff Stevens, chief executive officer of Psyched. "We are the only publicly traded company working with a legal psychoactive mushroom and we are advancing novel muscimol-based therapeutics using our proprietary extract, AME-1." Psyched Wellness Ltd. shares C.PSYC are trading up 17 cents at $0.48.

Read: